City Center Dermatology is categorized under Speech and Language Pathology Info Services in Elmhurst, NY .
City Center Dermatology was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Speech and Language Pathology Info Services business, which does work in the B2C market, and is classified as a Speech and Language Pathology Info Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Berry, Owner at the company’s single location by writing to 4037 74th St, Elmhurst, New York NY 11373 or by phoning (718) 651-7000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | City Center Dermatology |
| Contact Person: | Michael Berry, Owner |
| Address: | 4037 74th St, Elmhurst, New York 11373 |
| Phone Number: | (718) 651-7000 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Speech and Language Pathology Info Services |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
City Center Dermatology was started in 0 to provide professional Speech and Language Pathology Info Services under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Berry, Owner for inquiries that concern City Center Dermatology by calling the company number (718) 651-7000, as your correspondence is most welcome. Additionally, the physical location of the single location of City Center Dermatology can be found at the coordinates 40.745625,-73.891052 as well as the street address 4037 74th St in Elmhurst, New York 11373.
For its online presence, you may visit City Center Dermatology’s website at and engage with its social media outlets through on Twitter and on Facebook.